What Is Dual Diagnosis? Why Addiction and Mental Health Have to Be Treated Together

Two conditions, one person

Addiction rarely travels alone. A large share of people with a substance use disorder also live with a mental health condition such as anxiety, depression, PTSD, or bipolar disorder. When both are present at the same time, clinicians call it a dual diagnosis, or a co-occurring disorder. Neither condition is assumed to have caused the other. Substance use can worsen psychiatric symptoms, and untreated depression, trauma, psychosis, or anxiety can raise the risk of substance use or relapse. Often the two simply reinforce each other over time.

The scale of this is bigger than most families expect. In 2024, an estimated 21.2 million adults in the United States had both a mental illness and a substance use disorder, which is 8.1% of all adults, according to SAMHSA's 2024 National Survey on Drug Use and Health. Among adults with any mental illness that year, 61.5 million total, more than a third, 34.5%, also had a substance use disorder, per SAMHSA's national release data. Among people age 12 and older, 48.4 million, or 16.8%, had a substance use disorder in the past year, including 7.7 million who had both an alcohol use disorder and a drug use disorder at once, according to the same national annual report.

The problem with treating these conditions separately is simple: they feed each other. Someone drinking to quiet panic attacks will keep relapsing if the anxiety is never addressed. Someone whose depression lifts early in treatment can sink again the moment untreated cravings return. Intoxication and withdrawal can also mimic or mask psychiatric symptoms, which is one reason clinicians often need repeated assessments over time rather than a single intake interview to sort out what is substance-induced and what is an independent mental illness.

Why integrated care works

Integrated dual diagnosis treatment puts both conditions in front of the same clinical team at the same time. Instead of a person bouncing between an addiction program and a separate psychiatric provider who never speak to each other, one coordinated plan addresses the substance use and the mental health condition together. SAMHSA guidance specifically recommends that mental illness and substance use disorder be treated concurrently, with the intensity of treatment matched to the severity of both conditions rather than just one.

The evidence for this approach is strong. In a study published in the Journal of Systems and Integrative Neuroscience, 804 patients with co-occurring alcohol and mental health disorders were followed through a year of integrated treatment. Co-occurring mood problems such as anxiety and depression, along with opioid and cocaine misuse, dropped by between 66 and 95 percent at the one, six, and twelve month marks. Treating both conditions at once did not just help the addiction. It measurably improved the mental health condition too.

Despite that evidence, most people with co-occurring conditions are not getting help for both. SAMHSA's 2024 data show that 41.2% of adults with a co-occurring mental illness and substance use disorder received neither mental health nor substance use treatment that year, while 58.8%, or 12.5 million people, received at least one type. Cost, clinician shortages, transportation, housing instability, stigma, and programs that simply cannot treat both conditions all contribute to that gap.

What a real assessment involves

A program equipped for dual diagnosis care does more than ask about drug and alcohol use at intake. A thorough evaluation typically screens for depression, anxiety, trauma history, bipolar symptoms, psychosis, suicide risk, and medication-related risks alongside substance use. Because intoxication, withdrawal, medications, and medical conditions can all distort the picture, a good assessment accounts for the person's history and current state before settling on a diagnosis, and it revisits that diagnosis as symptoms clarify over time.

The ASAM Criteria, the framework most addiction programs use to determine level of care, evaluates a person across biomedical, psychological, and social dimensions rather than by substance alone. The fourth edition of the ASAM Criteria treats co-occurring conditions as an expected, routine part of addiction treatment rather than an exception, and it builds in enhanced capabilities for people whose psychiatric needs are more complex.

Matching the setting to the person

There is no single right level of care for dual diagnosis. The correct setting depends on withdrawal risk, overdose risk, psychiatric stability, medical needs, housing situation, and how much support the person has at home, not on the diagnosis alone.

• Outpatient care offers scheduled therapy, medication management, and recovery support while the person continues living at home. This tends to fit when symptoms and withdrawal risk are already stable.
• Intensive outpatient or partial hospitalization programs provide several hours of treatment on multiple days each week without an overnight stay. These settings can support medication adjustments, relapse prevention work, and psychiatric monitoring for someone who needs more structure than weekly outpatient visits.
• Residential treatment provides round-the-clock support in a protected environment, appropriate when someone needs to step fully out of their usual surroundings but does not require hospital-level medical care.
• Withdrawal management, sometimes called detox, offers clinically supervised support during withdrawal. Alcohol, benzodiazepine, and some sedative withdrawal can be medically dangerous and may need urgent evaluation. Withdrawal management alone is a stabilization step, not a complete treatment plan. Continued addiction and mental health treatment afterward is usually what reduces the risk of relapse.
• Crisis or emergency services are necessary for imminent suicide risk, severe intoxication, uncontrolled psychosis, or withdrawal that has become life-threatening.

What treatment includes once someone is in care

Care should be individualized to the specific diagnoses involved. Depending on the person, it may combine medications for opioid or alcohol use disorder, such as buprenorphine, methadone, naltrexone, acamprosate, or disulfiram, with psychotherapy approaches like cognitive behavioral therapy, motivational interviewing, contingency management, or trauma-focused therapy. Overdose prevention, including naloxone access and education, is a standard part of comprehensive care for anyone with opioid involvement. Family education, peer support, case management, and help navigating housing or benefits often round out the plan, because recovery rarely happens in isolation from the rest of a person's life.

Outpatient settings can deliver integrated care well. Programs such as East Point Behavioral Health build a single plan around both the substance use and the co-occurring condition, with day and evening options so people can get intensive care without leaving their jobs, families, or daily lives entirely behind.

Questions worth asking

A few questions separate genuinely integrated programs from ones that only use the words:

• Do you screen for mental health conditions at intake, or only substance use?
• Will the same team manage both, and do they communicate with each other?
• Is medication management, including medications for addiction treatment, available on site?
• How do you screen for suicide and overdose risk, and do you provide naloxone and a safety plan?
• How is progress on the mental health condition measured, not just sobriety?
• What happens if my symptoms worsen or this program cannot provide the level of care I need?

Safety and getting help now

A suspected overdose, seizures, severe confusion or hallucinations, suicidal intent, or severe withdrawal symptoms like tremor or vomiting are emergencies. Call emergency services, give naloxone if available and the situation involves opioids, and stay with the person until help arrives.

For non-emergency help finding care, 988 provides crisis support by call or text, SAMHSA's National Helpline is 1-800-662-HELP (4357), and FindTreatment.gov lists treatment options across the country. Because federal parity rules generally require many health plans to cover mental health and substance use benefits comparably to medical benefits, it is worth asking any insurer directly whether residential, outpatient, and medication treatment are covered, and requesting written criteria if a claim is denied.

A program that answers these questions clearly, and treats addiction while genuinely assessing depression, trauma, psychosis, and suicide risk, is one built around the whole person. That is the entire point of dual diagnosis care. If you or someone you love is weighing what to do next, the most useful next step is usually a conversation with a program that can evaluate both conditions together and explain, plainly, what treatment would actually look like.